Atlas Trials

Measurement of Relaxin Peptide in Multiple Sclerosis (MS)

Clinical trial NCT01909492 · COMPLETED

Trial details

NCT number
NCT01909492
Sponsor
Providence Health & Services
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis, Relapsing-Remitting
Start date
2013-09-20
Primary completion
2023-10-05
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.